Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphomaFrederick L. Locke, Jérôme Galon, Régis Perbost et al.|Nature Medicine|2024Cited by 114
Abstract 867: Multi-omic characterization of tumor microenvironment evolution in LBCL across treatment lines: Insights from Atlas classification and axicabtagene ciloleucel trialsMichael Mattie, Jérôme Galon, Régis Perbost et al.|Cancer Research|2025Cited by 0